Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Current Leases (2019 - 2023)

Marker Therapeutics (MRKR) has disclosed Current Leases for 5 consecutive years, with $665082.0 as the latest value for Q1 2023.

  • Quarterly Current Leases fell 2.76% to $665082.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $665082.0 through Mar 2023, down 2.76% year-over-year, with the annual reading at $577198.0 for FY2022, 6.98% down from the prior year.
  • Current Leases for Q1 2023 was $665082.0 at Marker Therapeutics, up from $577198.0 in the prior quarter.
  • The five-year high for Current Leases was $738389.0 in Q2 2022, with the low at $189791.0 in Q1 2019.
  • Average Current Leases over 5 years is $441696.5, with a median of $473077.0 recorded in 2021.
  • The sharpest move saw Current Leases surged 134.5% in 2020, then fell 15.67% in 2022.
  • Over 5 years, Current Leases stood at $204132.0 in 2019, then surged by 90.46% to $388792.0 in 2020, then soared by 59.59% to $620490.0 in 2021, then decreased by 6.98% to $577198.0 in 2022, then increased by 15.23% to $665082.0 in 2023.
  • According to Business Quant data, Current Leases over the past three periods came in at $665082.0, $577198.0, and $490449.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.